Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 18 (10), 90

Can Neuroimaging Provide Reliable Biomarkers for Obsessive-Compulsive Disorder? A Narrative Review

Affiliations
Review

Can Neuroimaging Provide Reliable Biomarkers for Obsessive-Compulsive Disorder? A Narrative Review

Ilana Frydman et al. Curr Psychiatry Rep.

Abstract

In this integrative review, we discuss findings supporting the use neuroimaging biomarkers in the diagnosis and treatment of obsessive-compulsive disorder (OCD). To do so, we have selected the most recent studies that attempted to identify the underlying pathogenic process associated with OCD and whether they provide useful information to predict clinical features, natural history or treatment responses. Studies using functional magnetic resonance (fMRI), voxel-based morphometry (VBM), diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in OCD patients are generally supportive of an expanded version of the earlier cortico-striatal-thalamus-cortical (CSTC) model of OCD. Although it is still unclear whether this information will be incorporated into the daily clinical practice (due to current conceptual approaches to mental illness), statistical techniques, such as pattern recognition methods, appear promising in identifying OCD patients and predicting their outcomes.

Keywords: Biomarkers; Diffusion tensor imaging; Functional magnetic resonance; Obsessive-compulsive disorder; Proton magnetic resonance spectroscopy; Voxel-based morphometry.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Am J Psychiatry. 2014 Mar;171(3):340-9 - PubMed
    1. Front Syst Neurosci. 2015 Dec 17;9:171 - PubMed
    1. PLoS One. 2012;7(4):e35889 - PubMed
    1. Clin Pharmacol Ther. 2001 Mar;69(3):89-95 - PubMed
    1. Cogn Behav Neurol. 2010 Sep;23(3):205-8 - PubMed

MeSH terms

LinkOut - more resources

Feedback